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In this work, we showed the presence of atrial natriuretic fac-
tor (ANF) in human prostate and compared its localisation in
normal and hyperplastic conditions. ANF was localised in
epithelial and stromal cells, being increased in hyperplasia,
mainly in the stromal component. Moreover, we compared
ANF and oxytocin positivity in the same glands, focusing on
the possible relationship between the paracrine effects of
these two hormones.
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T
he prostate is a composite organ constituted
of glandular and non glandular tissues and is
one of the major secretory contributors of the
seminal fluid.This function is hormonally regulated
and many local biochemical mechanisms are
involved.The paracrine role of oxytocin in the mod-
ulation of prostatic function has been recently elu-
cidated (Bodanszky et al, 1992; Nicholson 1996);
indeed, oxytocin is produced in the prostate under
androgen regulation, and it has been shown that it
increases the growth of epithelial tissue, muscular
tone and contractile activity, being, in turn, involved
also in the pathogenesis of benign prostatic hyper-
plasia (Frayne and Nicholson 1998; Nicholson and
Jenkin, 1995). In contrast, the presence and the
role of the atrial natriuretic factor (ANF), another
peptide with endocrine/paracrine functions in many
districts, has not been sufficiently investigated in the
male genital tract. ANF is involved in the regulation
of the renal excretion of sodium and water and in
the relaxation of vascular smooth muscle cells
(Currie et al., 1983). Moreover, ANF exerts a num-
ber of effects on several glands, such as the inhibi-
tion of aldosterone synthesis in adrenal cortical
cells (Atarashi et al, 1984), the release of vaso-
pressin from posterior pituitary gland (Samson
1985) and the production of renin in renal cortical
cells (Burnett et al., 1984); in addition, ANF has a
paracrine/autocrine function during spermiogenesis
in rats (Pandey and Orgebin-Crist, 1991). We have
previously demonstrated the presence of ANF in the
excretory ducts of the rabbit parotid gland
(Valentino et al., 1999), postulating the possible
paracrine role of this peptide in the regulation of
salivary composition. Finally, a number of studies
have recently shown a functional interaction
between oxytocin and ANF at many sites, such as
heart (Favaretto et al 1997), kidney (Soares et al
1999) and myometrium (Carvajal et al 2001).
Since it is known that oxytocin is present in pro-
static cells and has a role in the pathogenesis of
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prostatic hyperplasia, we have studied the presence
and the localisation of ANF in normal and hyper-
plastic human prostates, in order to clarify the pos-
sible role of this hormone in this organ and to inves-




Normal and hyperplastic prostatic tissues were
obtained at the Institute of Urology of the Poli-
clinico P. Giaccone of the University of Palermo,
Italy. Differential diagnoses between normal and
nodular hyperplasia were performed on 7-micra
Bouin’s liquid-fixed, paraffin-embedded, H&E-
stained sections. We collected ten biopsies from
both normal and hyperplastic prostates. Immuno-
Figure 1. Immunohistochemistry showing ANF and oxytocin localisation in normal and hyperplastic prostate. A) ANF in normal; B) ANF
in hyperplasia; C) oxytocin in normal; D) oxytocin in hyperplasia. Magnification 103. See text for more details.
Figure 2. Graph showing the different expression of ANF and
oxytocin in both epithelium and stroma of normal and hyper-
plastic prostates. See text for more details.
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histochemical analyses were performed on Bouin’s
liquid-fixed paraffin-embedded tissues; moreover, a
small specimen of each biopsy was frozen for
Western blotting study, as described below.
Immunohistochemistry
Immunostaining by the streptavidin-biotin com-
plex method (LSAB2 kit peroxidase, DAKO
Corporation, Carpinteria CA, Cat. No K0677) was
performed using monoclonal antibodies against ANF
at the dilution of 1:500 (Cymbus Biotechnology
LTD, Cat. No. CBL66) or against oxytocin at the
dilution of 1:1000 (Chemicon, Cat. No. AB911) on
5 µ-thick sections after Bouin’s fixation and paraf-
fin embedding; isotype-matched controls were also
used. After incubation for 10 min with protein block
serum-free (DAKO Corporation, USA, Cat. No
X0909), the primary antibody was added to the sec-
tions. DAB was used as develop chromogen (DAKO
Corporation, Cat. No K3467). Hematoxylin aqueous
formula (DAKO Corporation, Cat. No S2020) was
used as counterstaining. Results were semiquantitat-
ed by two independent observers, according to the
cell percentage presenting immunopositivity.
Western Blot analysis 
Twenty µg of total cell extracts to each lane and
a protein marker (Kaleidoscope prestained stan-
dard, Bio-Rad, Hercules CA, USA, Cat. No
1610324) were separated by electrophoresis on
denaturing 18% polyacrylamide slab gel (SDS-
PAGE) and transferred to nitrocellulose membrane
(Nitrocell Paper, Bio-Rad, Hercules CA, USA, Cat.
No 1620115). After 1 hour at room temperature
with a blocking buffer (5% low-fat dried milk in
TBST: 50mM Tris-HCl pH 7.5, 150 mM NaCl,
0.1% Tween-20) under gentle shaking, the mem-
brane was incubated with anti-ANF primary anti-
body (Cymbus Biotechnology LTD, Cat. No.
CBL66) at the dilution of 1:500, overnight at 4 °C.
After washing, the membrane was incubated with
HRP-conjugated secondary antibody (anti-mouse,
Pierce, 1:5000, Cheshire UK, Cat. No 31432) for 1
hour at room temperature with shaking and the
specific binding was detected using a chemilumines-
cent substrate (SuperSignal West Pico Chemilumi-
nescent Substrate, Pierce, Cheshire UK, Cat. No
34080) for autoradiography.
The same procedure was performed for oxytocin
analysis, using a denaturating 18% polyacrylamide
slab gel, primary antibody anti-oxytocin at a dilu-
tion of 1:1000, and secondary anti-mouse antibody
at a dilution of 1:10000.
Statistical analysis
Standard statistical analyses were applied to cal-
culate the means and the standard deviation. A one
way analysis of variance (ANOVA) was used to
determine the presence of differences within the
data obtained by immunostaining. Differences
between the means were regarded as significant
when a value of p<0.05 was obtained.
Results
Normal prostates showed classic tubulo-acinar
units lined by simple columnar epithelium and a few
basal cells surrounded by fibromuscular stroma;
prostatic concretions (corpora amylacea) were
sometimes present in the lumens. By contrast,
hyperplastic prostates were characterised by hyper-
plasia of both glandular and stromal components;
glands were dilated and epithelium ranged from
columnar to flat; papillary infoldings were fre-
quently present.
Immunostaining for ANF was positive in all nor-
mal and hyperplastic prostates. In particular, nor-
mal tissue showed cytoplasmic positivity of ANF in
glandular cells more than in stromal cells (Figure
1a); indeed, ANF resulted positive in 75% of glan-
dular cells and in 15% of stromal cells. Finally,
ANF glandular positivity was present in both basal
Figure 3. Western blot analysis showing an increase of both
ANF and oxytocin, from normal to hyperplastic prostate. N: nor-
mal; H: hyperplastic; OT: oxytocin. See text for more details.
 
and columnar cells. By contrast, we found a higher
positivity for ANF in nodular hyperplasia (Figure
1b); in particular, 88% of epithelial- and 60% of
stromal cells presented cytoplasmic positivity for
ANF. We found statistically significant differences
(p< 0.01) comparing stromal positivity in normal
and hyperplastic stroma; by contrast, differences
between positivity in normal and hyperplastic
epithelium were statistically not significant (p>
0.05) (Figure 2).
Immunostaining for oxytocin resulted positive in
glands of both normal and hyperplastic specimens
(Figures 1c, d). In particular, oxytocin positivity
was present in 37% of normal glandular cells and
67% of hyperplastic glandular cells and we found
these data statistically significant (p<0.02). By
contrast, the percentages of stromal cells present-
ing oxytocin positivity were 12% in normal and
15% in hyperplastic tissues; these data were not
statistically significant (p>0.05) (Figure 2). The
immunohistochemical observations were supported
by Western blot analysis, which showed a lower
expression of ANF and oxytocin in normal speci-
mens, compared to the higher expression of these
peptides in hyperplasia (Figure 3).
Discussion
Oxytocin is a peptide secreted by the hypothala-
mic magnocellular neurosecretory system, and
ANF is a peptide first extracted from atrial gran-
ules but is also found in other sites such as ventric-
ular myocardiocytes (Yamada et al., 1988), the
conduction system (Sola et al., 1990), atrioventric-
ular valves (Valentino et al., 1995), the excretory
system of kidney (McKenzie et al., 1991), the pan-
creas (Chabot et al., 1987) and the salivary glands
(Valentino et al. 1999). In particular, we have
recently demonstrated the presence of ANF in the
rabbit parotid gland and postulated that it may
play a role in the acinary cells and intralobular
ducts, suggesting its involvement in the composition
of saliva. Moreover, ANF was present in the extra-
lobular ducts and in the stromal vessels, being pos-
sibly involved in salivary fluidity (Valentino et al.
1999). Recent evidence supports a paracrine inter-
action between ANF and oxytocin, at different
sites. Haanwinckel et al. (1995) found that oxy-
tocin released from the neurohypophysis increased
the plasma concentration of ANF which, in turn,
induced natriuresis and diuresis. Moreover, Gutko-
wska et al. (1997) showed that oxytocin bound to
its receptors in myocardiocytes and induced the
release of ANF via a cGMP-mediated mechanism,
determining a rapid reduction of circulating blood
volume. In addition, Soares et al. (1999) demon-
strated an oxytocin-mediated natriuretic action of
ANF in renal tubules, with an increase of cGMP
concentration.
In the present study, we described the presence
and the localisation of ANF and oxytocin in normal
and hyperplastic human prostate. In the normal
prostate, we found ANF-immunopositive cells in
both glands and stroma. Because it is known that
ANF induces electrolyte and water transport, we
thought that the ANF present in glandular cells
could have a role in the electrolytic composition of
prostatic fluid, analogously to that in the parotid
gland (Valentino et al., 1999). Moreover, the ANF
present in the stromal cells adjacent to the
periglandular vessels could regulate the muscular
tone of these vessels, inducing vasodilatation and
regulating the fludity of prostatic liquid.
ANF-immunopositivity was increased in hyper-
plastic prostate, as shown by immunohistochem-
istry and confirmed by Western blot analysis; this
increase was different between epithelial and stro-
mal cells. In fact, we showed a modest increase of
ANF-positive glandular cells in hyperplasia, com-
pared to normal prostate tissue, while stroma pre-
sented a strong ANF positivity. An increase in oxy-
tocin was also noticed in the hyperplastic prostate
with the increase being found mainly in epithelial
cells.
Since both ANF and oxytocin are increased in
hyperplastic tissue, a relationship between these
hormones may be hypothesized, as, in fact, has been
shown in other organs. In particular, a paracrine
action of oxytocin on the ANF-positive cells may be
presumed, as has already been demonstrated in the
heart (Gutkowska et al., 1997); indeed, ANF over-
expression in hyperplastic prostates could be
induced by oxytocin, via a paracrine mechanism.
Moreover, many authors have clarified the role of
oxytocin in the pathogenesis of nodular hyperpla-
sia. In particular, the expression of oxytocin recep-
tors on glandular cells of prostate is regulated by
androgens, such as testosterone, and oxytocin could
have a paracrine action on epithelial cells, inducing
prostatic growth (Frayne and Nicholson 1998;
Nicholson and Jenkin, 1995). Therefore, the
increase in glandular oxytocin-positive cells seems
to be related to prostatic hyperplasia. Similarly, the
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statistically significant increase in ANF in stromal
cells of the hyperplastic prostates might also be
related to prostatic hyperplasia. Lee et al (1988)
reported that ANF binds with high affinity to ANF
receptors on human fibroblasts; this led us to pos-
tulate that ANF also has a paracrine action on pro-
static fibroblasts. As a consequence, it is possible
that the peptides have different roles in the patho-
genesis of prostatic hyperplasia: oxytocin could
induce the growth of glandular tissue; ANF could
stimulate the growth of the stromal component.
In conclusion, to our knowledge, this is the first
report demonstrating ANF positivity and localisa-
tion in normal and hyperplastic prostates; we pos-
tulate that it plays a physiological role in the secre-
tion of prostatic fluid and we suspect a probable
implication in prostatic hyperplasia pathogenesis;
however, at this stage, the existence of this interac-
tion needs further confirmation.
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